The nonprofit health organization’s MediMap tests were used by physicians in the Inova Genomics Laboratory to predict drug dosage, side effects and efficiency for patients.
On April 4, the FDA issued a letter to Inova warning that claims on the lab’s website were in violation of the Federal Food, Drug, and Cosmetic Act. Though Inova claimed the MediMap tests could predict patient responses to drugs, the FDA noted that it had not approved the tests’ safety and accuracy.
More articles on health IT:
Harvard Medical School’s AI screening system could produce more accurate cancer treatment programs
Microsoft emails users about data breach within customer support platform
California nursing program uses human-like robots to train medical personnel
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
